Nuclear cardiology needs new "blood"

Journal of Nuclear Cardiology

Volumn 16, Issue 2, 2009, Pages 180-183

  Saraste, Antti ^a   Nekolla, Stephan ^a   Schwaiger, Markus ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BMS 747158 02; FLUORINE 18; FLUOROBENZYL TRIPHENYLPHOSPHONIUM F 18; FLUORODIHYDROROTENONE F 18; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; NITROGEN 13; OXYGEN 15; RADIOPHARMACEUTICAL AGENT; RUBIDIUM 82; TECHNETIUM 99M; THALLIUM 201; UNCLASSIFIED DRUG; BMS 747158-02; DIAGNOSTIC AGENT; PYRIDAZINE DERIVATIVE;

CLINICAL PROTOCOL; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CORONARY FLOW RESERVE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; EDITORIAL; FALSE POSITIVE RESULT; HEART CATHETERIZATION; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HEART SCINTISCANNING; HUMAN; IMAGE ANALYSIS; IMAGE QUALITY; INTERMETHOD COMPARISON; NONHUMAN; PATIENT SELECTION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RADIATION ATTENUATION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; CARDIOLOGY; CORONARY ARTERY DISEASE; IMAGE ENHANCEMENT; METHODOLOGY; NUCLEAR MEDICINE; SCINTISCANNING;

CARDIOLOGY; CORONARY ARTERY DISEASE; HUMANS; IMAGE ENHANCEMENT; NUCLEAR MEDICINE; POSITRON-EMISSION TOMOGRAPHY; PYRIDAZINES; RADIOPHARMACEUTICALS;

EID: 67649948193     PISSN: 10713581     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12350-009-9055-3     Document Type: Editorial

References (24)

1. Klocke FJ, Baird MG, Lorell BH, Bateman TM, Messer JV, Berman DS, et al. ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging - executive summary: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionuclide Imaging). J Am Coll Cardiol 2003;42:1318-33.
2. Redberg RF, Walsh J. Pay now, benefits may follow - the case of cardiac computed tomographic angiography. N Engl J Med 2008;359:2309-11.
3. Zaret BL, Strauss HW, Martin ND, Wells HP Jr, Flamm MD Jr. Noninvasive regional myocardial perfusion with radioactive potassium. Study of patients at rest, with exercise and during angina pectoris. N Engl J Med 1973;288:809-12.
4. 15O. Circulation 1984;70:724-33.
5. Hutchins GD, Schwaiger M, Rosenspire KC, Krivokapich J, Schelbert H, Kuhl DE. Noninvasive quantification of regional blood flow in the human heart using N-13 ammonia and dynamic positron emission tomographic imaging. J Am Coll Cardiol 1990;15:1032-42.
6. DiCarli MF, Hachamovitch R. New technology for noninvasive evaluation of coronary artery disease. Circulation 2007;115:1464-80.
7. Gould KL, Lipscomb K. Effects of coronary stenoses on coronary flow reserve and resistance. Am J Cardiol 1974;34:48-55.
8. Uren NG, Melin JA, De Bruyne B, Wijns W, Baudhuin T, Camici PG. Relation between myocardial blood flow and the severity of coronary-artery stenosis. N Engl J Med 1994;330:1782-8.
9. Dayanikli F, Grambow D, Muzik O, Mosca L, Rubenfire M, Schwaiger M. Early detection of abnormal coronary flow reserve in asymptomatic men at high risk for coronary artery disease using positron emission tomography. Circulation 1994;90:808-17.
10. Schindler TH, Nitzsche EU, Schelbert HR, Olschewski M, Sayre J, Mix M, et al. Positron emission tomography-measured abnormal responses of myocardial blood flow to sympathetic stimulation are associated with the risk of developing cardiovascular events. J Am Coll Cardiol 2005;45:1505-12.
11. Neglia D, Michelassi C, Trivieri MG, Sambuceti G, Giorgetti A, Pratali L, et al. Prognostic role of myocardial blood flow impairment in idiopathic left ventricular dysfunction. Circulation 2002;105:186-93.
12. Cecchi F, Olivotto I, Gistri R, Lorenzoni R, Chiriatti G, Camici PG. Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy. N Engl J Med 2003;349:1027-35.
13. Schächinger V, Britten MB, Zeiher AM. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 2000;101:1899-906.
14. Goldstein RA, Mullani NA, Marani SK, Fisher DJ, Gould KL, O'Brien HA Jr. Myocardial perfusion with rubidium-82. II. Effects of metabolic and pharmacologic intervention. J Nucl Med 1983;24:907-15.
15. Marshall RC, Powers-Risius P, Reutter BW, O'Neil JP, La Belle M, Huesman RH, et al. Kinetic analysis of 18F-fluorodihydrorotenone as a deposited myocardial flow tracer: Comparison to 201Tl. J Nucl Med 2004;45:1950-9.
16. Madar I, Ravert H, Dipaula A, Du Y, Dannals RF, Becker L. Assessment of severity of coronary artery stenosis in a canine model using the PET agent 18F-fluorobenzyl triphenyl phosphonium: Comparison with 99mTc-tetrofosmin. J Nucl Med 2007;48:1021-30.
17. Yalamanchili P, Wexler E, Hayes M, Yu M, Bozek J, Kagan M, et al. Mechanism of uptake and retention of F-18 BMS-747158-02 in cardiomyocytes: A novel PET myocardial imaging agent. J Nucl Cardiol 2007;14:782-8.
18. Yu M, Guaraldi MT, Mistry M, Kagan M, McDonald JL, Drew K, et al. BMS-747158-02: A novel PET myocardial perfusion imaging agent. J Nucl Cardiol 2007;14:789-98.
19. Schuler F, Casida JE. The insecticide target in the PSST subunit of complex I. Pest Manag Sci 2001;57:932-40.
20. Huisman MC, Higuchi T, Reder S, Nekolla SG, Poethko T, Wester HJ, et al. Initial characterization of an 18F-labeled myocardial perfusion tracer. J Nucl Med 2008;49:630-6.
21. Higuchi T, Nekolla SG, Huisman MM, Reder S, Poethko T, Yu M, et al. A new 18F-labeled myocardial PET tracer: Myocardial uptake after permanent and transient coronary occlusion in rats. J Nucl Med 2008;49:1715-22.
22. Nekolla S, Reder S, Saraste A, Dewas G, Preissl A, Huisman M, et al. Initial characterization of the myocardial perfusion PET agent 18-F-BMS-747158-02 in comparison to 13-N ammonia and microspheres in a pig model. Eur J Nucl Med Mol Imaging 2008;35:S195 (abstract).
23. Sherif HM, Saraste A, Higuchi T, Reder S, Weidl E, Weber A, et al. Evaluation of the novel PET perfusion tracer 18F BMS747158-02 for measurement of myocardial infarct size in a rat model of permanent left coronary artery ligation and ischemia-reperfusion. Eur J Nucl Med Mol Imaging 2008;35:S194 (abstract).
24. Maddahi J, Schiepers C, Czernin J, Huang H, Schelbert H, Wijatyk A, et al. First human study of BMS747158, a novel F-18 labeled tracer for myocardial perfusion imaging. J Nucl Med 2008;49:70P (abstract).